ANI PHARMACEUTICALS INC — Director's Dealing 2010

Feb 3, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOSANTE PHARMACEUTICALS INC (bpax)
CIK: 0001023024
Period of Report: 2010-02-02

Reporting Person: SIMES STEPHEN M (Director, V Chair, Pres. and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-02-02	Employee Stock Option (right to buy)	$1.54	A	150000	Acquired	2020-02-01	Common Stock (150000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	197167	Indirect
Common Stock	100	Indirect

Footnotes

F1: This option vests with respect to 50,000 shares on each of February 2, 2011, February 2, 2012 and February 2, 2013.